Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
about
Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.Comparison of Mortality between Japanese Peritoneal Dialysis and Hemodialysis Patients: A 5-Year Multicenter Follow-Up Study.A brief recap of tips and surgical manoeuvres to enhance optimal outcome of surgically placed peritoneal dialysis catheters.Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.Insulin demand regulates β cell number via the unfolded protein response.Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D studyThe Significance of Ultrasound in Determining Whether SHPT Patients Are Sensitive to Calcitriol Treatment.Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl.Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism.Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study.Therapeutic management of post-kidney transplant hyperparathyroidism.Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.Diseases of the parathyroid gland in chronic kidney disease.Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.Hyperparathyroidism in chronic kidney disease patients: an update on current pharmacotherapy.The effect of vitamin D status on risk factors for cardiovascular disease.Medical management after parathyroid interventionPathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.Control of severe hyperparathyroidism in dialysis patients with nodular hyperplasia.Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism.Local calcitriol injections as a suppressive treatment of secondary hyperparathyroidism in chronic dialysis patients.Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question.A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
P2860
Q33878430-7829BEC7-93A8-48F6-B3B3-3B2FB8E6AD52Q34362759-82FFDFBF-6119-4671-A550-2BC50F217A0FQ36014552-C95C9BDA-4103-47D6-8ABB-46163E330637Q36128744-CACC74AA-0747-40F1-A3C6-7127019059CDQ36162579-6EFEA2BC-6EAF-4FB7-ADDF-2C88B96FBBD2Q36165645-713F0DD4-AB2C-449B-9122-E5AC6D50D1E1Q36199558-C305DFC1-13F4-4E30-8E90-8C8249D4B159Q36680782-90A6D0C9-3C6E-4C42-B357-9D4BC56FA1DBQ37092793-0D52D550-6187-47C9-ACD2-D8980164C090Q37231801-68C5475B-EF68-4600-87C2-26B022C3A6BAQ37378259-47DBFCFD-F59A-416B-A633-3A88F705E5E6Q37767247-C658577C-E830-414D-8F9E-72A157734616Q37807991-5EF61442-6B2F-4813-BEE7-BC83EA4C5BA0Q37912038-4C65C6D8-01BC-4D59-9750-0A152ABA69C5Q38078963-5E9D1B7B-E9B3-4D73-BCCF-78A77375EF71Q38092144-B7E566D7-89C4-4469-AAAF-B21C4360138BQ38100985-15E80E13-AFBC-4CE1-9422-744410407D24Q38487229-F7D242CD-1669-4CFD-8698-E953A9530C9AQ40318301-4986F46E-E64C-430B-AB2E-B211FF8C0FF7Q40318438-F2A6B267-6956-452E-9A6F-834CBA21E811Q44227454-7AA53B08-38C1-4048-85C6-B937DC8DC45DQ46860322-B1627735-096F-4416-B1CE-1ECEF825021DQ48239717-B8DBE360-731E-4EAE-ADBC-EDF458EFF7F5Q53586090-025D119D-EBFD-4B6C-99D6-F837C9BD7345
P2860
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
@ast
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
@en
type
label
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
@ast
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
@en
prefLabel
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
@ast
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
@en
P356
P1476
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease
@en
P2093
J J Kazama
S Nakanishi
P356
10.1038/SJ.KI.5001594
P577
2006-07-01T00:00:00Z